Source: Annual Congress 2008 - Basic science in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Black, L. Wu, L. Nicholson (Auckland, New Zealand). Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease. Eur Respir J 2008; 32: Suppl. 52, 3565

Member's Comments

No comment yet.

Related content which might interest you: Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review Source: Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018 Year: 2019 Decreased circulatory receptor for advanced glycation end-products is associated with poorer survival in patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Plasma advanced glycation end-products and skin autofluorescence are increased in COPD Source: Eur Respir J 2014; 43: 430-438 Year: 2013 Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Advanced glycation endproducts and lung function in COPD Source: International Congress 2014 – Best posters in chronic care Year: 2014 Measures of lung function and their relationship with advanced glycation end-products Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019 Year: 2020 Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Colonization in advanced chronic obstructive pulmonary disease Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016